Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Natalia S. Tsaplina"'
Publikováno v:
Современная онкология, Vol 25, Iss 1, Pp 78-81 (2023)
Background. Introduction a targeted drugs in a real clinical practice bring a vast improvement of prognosis in patients with relapsed and refractory (r/r) Hodgkin lymphoma (HL). But it is necessary to increase the experience in anti-CD30 monoclonal a
Externí odkaz:
https://doaj.org/article/e5bf6c82b46a4b809c5b08383fded283
Autor:
Natalia S. Tsaplina, Timur T. Valiev, Galina D. Petrova, Kirill I. Kirgizov, Svetlana R. Varfolomeeva
Publikováno v:
Современная онкология, Vol 24, Iss 3, Pp 319-324 (2022)
An advance of Hodgkin lymphoma (HL) diagnostic and treatment protocols promoted between fatal and high-curative disease. Modern treatment programs can reach many-year survival rate in 8097% even in patients with advanced (IIIIV) HL stages and unfavor
Externí odkaz:
https://doaj.org/article/0cf2e81a5cf7488d90f4e96d00a2fabf